New PLCO Data: SCU Ancillary data and Vitamin D lab results
Posted on June 11, 2014, 1 a.m. in PLCO
New PLCO cancer data added. Data version: may14.d052114
- New Inadequate FSG variables:
- The variables fsgin0/3/5/35 were removed from the colon person file.
- The new variable fsg_in was added to the screening file, and the variables fsg_in0/3/5/35 were added to the person file. See documentation for variable formats.
- New Hematopoetic Cancer Type variable:
- The variable hema_type was given a new format in the hema_prsn file. See documentation for variable formats.
- The variable hema_subtype has been dropped.
- New SCU Complications variable indicating whether or not a complication was added from the SCU data.
- Hematopoietic Non-target Misc Cancers:
- Cancers with ICD codes classified as Non-Hodgkins Lymphoma, myeloproliferative disease, or myelodysplastic syndrome have been improved by classifying them as confirmed borderline hematopoietic cancers.
New PLCO ancillary study data added:
New PLCO lab data added:
The total PLCO population now has 154,898 participants. Over the course of the trial this number decreases due to participants withdrawing, improper consent at randomization or duplication at randomization.